Search

Now showing items 1-2 of 2

Ombitasvir / paritaprevir / ritonavir / dasabuvir ± ribavirina es segura y efectiva en el HCV - infectados pacientes en una vida real cohorte de América Latina .

Mendizabal, Manuel.; Haddad, Leila.; Gallardo, Patricia.; Ferrada, Alejandro.; Soza, Alejandro.; Adrover, Raul.; Aravena, Edmundo. (Wiley, 2017-03-29)

Information about the use of ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin (OBV/PTV/r/DSV ± RBV) in real-clinical practice in Latin America is scarce. We aimed to confirm safety and effectiveness of OBV/PTV/r/DSV ± RBV ...

Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America.

Mendizabal, Manuel.; Haddad, Leila.; Gallardo, Patricia.; Ferrada, Alejandro.; Soza, Alejandro.; Adrover, Raul.; Aravena, Edmundo.; et al. (Wiley, 2017-09-01)

Information about the use of ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin (OBV/PTV/r/DSV ± RBV) in real-clinical practice in Latin America is scarce. We aimed to confirm safety and effectiveness of OBV/PTV/r/DSV ± RBV ...